10761763

Source:http://linkedlifedata.com/resource/pubmed/id/10761763

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0024305, umls-concept:C0034656, umls-concept:C0059985, umls-concept:C0092801, umls-concept:C0205269, umls-concept:C0205390, umls-concept:C2603343
pubmed:issue	2
pubmed:dateCreated	2000-6-21
pubmed:abstractText	It is unclear whether the purine analogs fludarabine (Flu) and cladribine (CdA) are non-resistant.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9007735
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Cladribine, http://linkedlifedata.com/resource/pubmed/chemical/Vidarabine, http://linkedlifedata.com/resource/pubmed/chemical/fludarabine
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	0923-7534
pubmed:author	pubmed-author:BalzarottiMM, pubmed-author:BonadonnaGG, pubmed-author:De PaoliAA, pubmed-author:LuoniMM, pubmed-author:RampinelliII, pubmed-author:SantoroAA, pubmed-author:TondiniCC, pubmed-author:ValagussaPP
pubmed:issnType	Print
pubmed:volume	11
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	231-3
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:10761763-Adult, pubmed-meshheading:10761763-Aged, pubmed-meshheading:10761763-Antineoplastic Agents, pubmed-meshheading:10761763-Cladribine, pubmed-meshheading:10761763-Confidence Intervals, pubmed-meshheading:10761763-Cross-Over Studies, pubmed-meshheading:10761763-Disease-Free Survival, pubmed-meshheading:10761763-Dose-Response Relationship, Drug, pubmed-meshheading:10761763-Drug Administration Schedule, pubmed-meshheading:10761763-Drug Resistance, Neoplasm, pubmed-meshheading:10761763-Female, pubmed-meshheading:10761763-Follow-Up Studies, pubmed-meshheading:10761763-Hematologic Diseases, pubmed-meshheading:10761763-Humans, pubmed-meshheading:10761763-Infusions, Intravenous, pubmed-meshheading:10761763-Lymphoma, Non-Hodgkin, pubmed-meshheading:10761763-Male, pubmed-meshheading:10761763-Middle Aged, pubmed-meshheading:10761763-Recurrence, pubmed-meshheading:10761763-Survival Rate, pubmed-meshheading:10761763-Vidarabine
pubmed:year	2000
pubmed:articleTitle	Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma: a phase II randomized study.
pubmed:affiliation	Division of Medical Oncology, Istituto Nazionale Tumori, Milan, Italy. tondini@istitutotumori.mi.it
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II